MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma - Chapel, David B.; Schulte, Jefree J.; Berg, Kyra; Churg, Andrew; Dacic, Sanja; Fitzpatrick, Carrie; Galateau-Salle, Francoise; Hiroshima, Kenzo; Krausz, Thomas; Le Stang, Nolwenn; McGregor, Stephanie; Nabeshima, Kazuki; et al. (Modern pathology, 2020)
Keywords: 13/51; 38/32; 631/67/1641; 692/53/2421; 692/699/67/1641; Biomarkers, Tumor - analysis; Biomarkers, Tumor - genetics; Copy number; Cyclin-Dependent Kinase Inhibitor p16 - genetics; Diagnosis; Fluorescence in situ hybridization; France; Gene deletion; Humans; Hybridization; Immunohistochemistry; In Situ Hybridization, Fluorescence; Laboratories; Laboratory Medicine; Medical diagnosis; Medicine; Medicine & Public Health; Mesothelioma; Mesothelioma, Malignant - enzymology; Mesothelioma, Malignant - genetics; Mesothelioma, Malignant - pathology; North America; Observer Variation; Pathology; Pleural Neoplasms - enzymology; Pleural Neoplasms - genetics; Pleural Neoplasms - pathology; Predictive Value of Tests; Purine-Nucleoside Phosphorylase - analysis; Reproducibility of Results; Tokyo; France; Tokyo; North America